Hematology
Paul Richardson, MD
Director in 2001, and led the study and development of several pivotal novel drugs including thalidomide, lenalidomide, bortezomib, pomalidomide, panobinostat; Professor of Medicine at Harvard Medical School in 2012, and then became Clinical Program Leader and Director of Clinical Research in 2014.
Milford, MA
Unlock Paul Richardson's Full Profile
Enter your email to access detailed credentials, peer recognition, clinical focus areas, and practice information for all specialists.